BASF confirms exploratory talks with Evonik on potential takeover of German chemical rival

BASF has made an unofficial approach to German chemical rival Evonik regarding a potential voluntary public takeover offer for all its shares, both companies confirmed on Friday. Evonik stated in an ad-hoc release that no discussions are currently taking place, while BASF described the move as “exploratory talks” with Evonik and its majority shareholder, the RAG Foundation, which holds 43% of Evonik’s stock. The RAG Foundation acknowledged the approach but declined further comment.
Evonik’s market capitalization stands at approximately €8.5 billion, with its enterprise value estimated at €12 billion including debt. BASF, valued at around €47 billion, has engaged banks to assess financing options, with insiders suggesting a cash or share swap could be considered. The deal remains in a preliminary stage, and no formal offer has been submitted, according to financial and corporate sources.
Investors reacted swiftly: Evonik shares surged up to 11% to over €20, their highest level since May 2025, while BASF shares fell by more than 3%. Arne Rautenberg, head of equities at Union Investment, said the industrial logic is sound, noting Evonik’s product portfolio is complementary to BASF’s. A combined entity would generate roughly €75 billion in revenue, positioning it as a global leader in the chemicals sector.
BASF has previously signaled a focus on strengthening core businesses and reducing debt, which currently stands at around €20 billion. The company has not commented beyond confirming the exploratory nature of the discussions. Evonik, under interim CEO Claus Rettig, is restructuring amid industry challenges, including plans to cut 3,200 jobs by 2029, 2,150 of them in Germany.
Follow us for live European news
- 4
- 1
- 1
1 further source not geolocated



